Proofs of partial knowledge and simplified design of witness hiding protocols

Suppose we are given a proof of knowledge P in which a prover demonstrates that he knows a solution to a given problem instance. Suppose also that we have a secret sharing scheme S on n participants. Then under certain assumptions on P and S , we show how to transform P into a witness indistinguishable protocol, in which the prover demonstrates knowledge of the solution to some subset of n problem instances out of a collection of subsets defined by S . For example, using a threshold scheme, the prover can show that he knows at least d out of n solutions without revealing which d instances are involved. If the instances are independently generated, we get a witness hiding protocol, even if P did not have this property. Our results can be used to efficiently implement general forms of group oriented identification and signatures. Our transformation produces a protocol with the same number of rounds as P and communication complexity n times that of P . Our results use no unproven complexity assumptions

Proofs of partial knowledge and simplified design of witness hiding protocols

Suppose we are given a proof of knowledge P in which a prover demonstrates that he knows a solution to a given problem instance. Suppose also that we have a secret sharing scheme S on n participants. Then under certain assumptions on P and S , we show how to transform P into a witness indistinguishable protocol, in which the prover demonstrates knowledge of the solution to some subset of n problem instances out of a collection of subsets defined by S . For example, using a threshold scheme, the prover can show that he knows at least d out of n solutions without revealing which d instances are involved. If the instances are independently generated, we get a witness hiding protocol, even if P did not have this property. Our results can be used to efficiently implement general forms of group oriented identification and signatures. Our transformation produces a protocol with the same number of rounds as P and communication complexity n times that of P . Our results use no unproven complexity assumptions

A novel mammalian expression system derived from components coordinating nicotine degradation in arthrobacter nicotinovorans pAO1

We describe the design and detailed characterization of 6-hydroxy-nicotine (6HNic)-adjustable transgene expression (NICE) systems engineered for lentiviral transduction and in vivo modulation of angiogenic responses. Arthrobacter nicotinovorans pAO1 encodes a unique catabolic machinery on its plasmid pAO1, which enables this Gram-positive soil bacterium to use the tobacco alkaloid nicotine as the exclusive carbon source. The 6HNic-responsive repressor-operator (HdnoR-O(NIC)) interaction, controlling 6HNic oxidase production in A.nicotinovorans pAO1, was engineered for generic 6HNic-adjustable transgene expression in mammalian cells. HdnoR fused to different transactivation domains retained its O(NIC)-binding capacity in mammalian cells and reversibly adjusted transgene transcription from chimeric O(NIC)-containing promoters (P(NIC); O(NIC) fused to a minimal eukaryotic promoter [P(min)]) in a 6HNic-responsive manner. The combination of transactivators containing various transactivation domains with promoters differing in the number of operator modules as well as in their relative inter-O(NIC) and/or O(NIC)-P(min) spacing revealed steric constraints influencing overall NICE regulation performance in mammalian cells. Mice implanted with microencapsulated cells engineered for NICE-controlled expression of the human glycoprotein secreted placental alkaline phosphatase (SEAP) showed high SEAP serum levels in the absence of regulating 6HNic. 6HNic was unable to modulate SEAP expression, suggesting that this nicotine derivative exhibits control-incompatible pharmacokinetics in mice. However, chicken embryos transduced with HIV-1-derived self-inactivating lentiviral particles transgenic for NICE-adjustable expression of the human vascular endothelial growth factor 121 (VEGF(121)) showed graded 6HNic response following administration of different 6HNic concentrations. Owing to the clinically inert and highly water-soluble compound 6HNic, NICE-adjustable transgene control systems may become a welcome alternative to available drug-responsive homologs in basic research, therapeutic cell engineering and biopharmaceutical manufacturing

A novel mammalian expression system derived from components coordinating nicotine degradation in arthrobacter nicotinovorans pAO1

We describe the design and detailed characterization of 6-hydroxy-nicotine (6HNic)-adjustable transgene expression (NICE) systems engineered for lentiviral transduction and in vivo modulation of angiogenic responses. Arthrobacter nicotinovorans pAO1 encodes a unique catabolic machinery on its plasmid pAO1, which enables this Gram-positive soil bacterium to use the tobacco alkaloid nicotine as the exclusive carbon source. The 6HNic-responsive repressor-operator (HdnoR-ONIC) interaction, controlling 6HNic oxidase production in A.nicotinovorans pAO1, was engineered for generic 6HNic-adjustable transgene expression in mammalian cells. HdnoR fused to different transactivation domains retained its ONIC-binding capacity in mammalian cells and reversibly adjusted transgene transcription from chimeric ONIC-containing promoters (PNIC; ONIC fused to a minimal eukaryotic promoter [Pmin]) in a 6HNic-responsive manner. The combination of transactivators containing various transactivation domains with promoters differing in the number of operator modules as well as in their relative inter-ONIC and/or ONIC-Pmin spacing revealed steric constraints influencing overall NICE regulation performance in mammalian cells. Mice implanted with microencapsulated cells engineered for NICE-controlled expression of the human glycoprotein secreted placental alkaline phosphatase (SEAP) showed high SEAP serum levels in the absence of regulating 6HNic. 6HNic was unable to modulate SEAP expression, suggesting that this nicotine derivative exhibits control-incompatible pharmacokinetics in mice. However, chicken embryos transduced with HIV-1-derived self-inactivating lentiviral particles transgenic for NICE-adjustable expression of the human vascular endothelial growth factor 121 (VEGF121) showed graded 6HNic response following administration of different 6HNic concentrations. Owing to the clinically inert and highly water-soluble compound 6HNic, NICE-adjustable transgene control systems may become a welcome alternative to available drug-responsive homologs in basic research, therapeutic cell engineering and biopharmaceutical manufacturin

Evaluation of bicinchoninic acid as a ligand for copper(I)-catalyzed azide-alkyne bioconjugations

Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG geförderten) Allianz- bzw. Nationallizenz frei zugänglich.This publication is with permission of the rights owner freely accessible due to an Alliance licence and a national licence (funded by the DFG, German Research Foundation) respectively.The Cu(I)-catalyzed cycloaddition of terminal azides and alkynes (click chemistry) represents a highly specific reaction for the functionalization of biomolecules with chemical moieties such as dyes or polymer matrices. In this study we evaluate the use of bicinchoninic acid (BCA) as a ligand for Cu(I) under physiological reaction conditions. We demonstrate that the BCA–Cu(I)-complex represents an efficient catalyst for the conjugation of fluorophores or biotin to alkyne- or azide-functionalized proteins resulting in increased or at least equal reaction yields compared to commonly used catalysts like Cu(I) in complex with TBTA (tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) or BPAA (bathophenanthroline disulfonic acid). The stabilization of Cu(I) with BCA represents a new strategy for achieving highly efficient bioconjugation reactions under physiological conditions in many application fields.EC/FP7/259043/EU/Computing Biomaterials/COMPBIOMATDFG, EXC 294, BIOSS Zentrum für Biologische Signalstudien - von der Analyse zur SyntheseDFG, GSC 4, Spemann Graduiertenschule für Biologie und Medizin (SGBM

Multi-authority secret-ballot elections with linear work

We present new cryptographic protocols for multi-authority secret ballot elections that guarantee privacy, robustness, and universal verifiability. Application of some novel techniques, in particular the construction of witness hiding/indistinguishable protocols from Cramer, Damgaard and Schoenmakers, and the verifiable secret sharing scheme of Pedersen, reduce the work required by the voter or an authority to a linear number of cryptographic operations in the population size (compared to quadratic in previous schemes). Thus we get significantly closer to a practical election scheme